Skip to main content

Table 1 Baseline characteristics of subjects enrolled in the study

From: Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction

  SEREX AlphaLISA
TIAa
(n = 19)
Stroke HD
(n = 285)
TIA
(n = 92)
aCI
(n = 464)
oCI
(n = 65)
Age 68.3*** (± 10.2) 70.2*** (± 11.6) 75.5*** (± 11.5) 73.3*** (± 9.2) 52.3 (± 11.7)
Male sex 16 (84.2%) 55 (59.7%) 271 (58.4%) 48 (73.8%) 188 (65.9%)
HT 13*** (68.4%) 60*** (65.2%) 335*** (72.2%) 53*** (81.5%) 57 (20.0%)
DM 3*** (15.8%) 27*** (29.3%) 125*** (26.9%) 22*** (33.8%) 11 (3.9%)
HL 3 (15.8%) 36*** (39.1%) 122*** (26.3%) 25*** (38.5%) 40 (14.0%)
CHD 1*** (5.2%) 5*** (5.4%) 40*** (8.6%) 2*** (3.1%) 0
Obesity (BMI ≥ 25) 10 (52.6%) 30 (32.6%) 127 (27.4%) 11 (16.9%) 88 (30.9%)
Smoking 12 (63.1%) 43 (46.7%) 228 (49.1%) 33 (50.8%) 132 (46.3%)
  1. Data represents means (± SD) for continuous data and n (%) for categorical data
  2. aTIA transient ischemic attack, aCI acute cerebral infarction, HD healthy donor, oCI old cerebral infarction, HT hypertension, DM diabetes mellitus, HL hyperlipidemia, CHD coronary heart disease, BMI body mass index
  3. *** P < 0.001 vs. HD